Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.00%
)
US TECH 100
24,038.40
(
-0.39%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
104.75
(
4.07%
)
Bitcoin
72,512.28
(
-1.93%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RockRat post# 106546

Monday, 10/18/2010 8:27:27 PM

Monday, October 18, 2010 8:27:27 PM

Post# of 257253
Thanks, Rockrat. Daiichi Sankyo’s Edoxaban (DU-176b) has its own section in the “What’s New in the Anticoagulant Market?” compilation in #msg-55640904. Regards, Dew

p.s. The above compilation is accessible from the MNTA ReadMeFirst, but the version referenced there is not always up to date. To access the latest version, please use the link in the iBox of the Biotech Values board.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up